G. Steiger

发表

Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes

S. Sadallah, J. Schifferli, J. Carpentier, 1994, The Journal of experimental medicine.

Difference in the biological properties of the two forms of the fourth component of human complement (C4).

A. Sjöholm, J. Schifferli, J. Paccaud, 1986, Clinical and experimental immunology.

Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE)

N. Madi, G. Steiger, J. Schifferli, 1991, Clinical and experimental immunology.

Reduced immune adherence of antigen/antibody complexes formed in the presence of complement in vivo and in vitro.

J. Schifferli, J. Paccaud, G. Steiger, 1989, Complement and inflammation.

Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement.

J. Schifferli, J. Ryser, A. Dash, 1987, Clinical and experimental immunology.

Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS

J. Schifferli, C. Danielsson, M. Pascual, 1994, European journal of immunology.

Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.

A. Sjöholm, J. Schifferli, P. Spaeth, 1985, The Journal of clinical investigation.

Ether link cleavage is the major pathway of iodothyronine metabolism in the phagocytosing human leukocyte and also occurs in vivo in the rat.

A. Burger, B. Babior, S. Ingbar, 1983, The Journal of clinical investigation.

Milk, cream and evaporated milk. Determination of the total solids content (Reference method). Revision of Provisional IDF Standard 21A:1982

G. Steiger, R. Martens, G. Steiger, 1986 .

Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.

J. Schifferli, A. Pechère, J. Paccaud, 1993, Journal of immunology.

Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition--higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia).

J. Saurat, J. Dayer, L. Didierjean, 1991, The Journal of allergy and clinical immunology.

Activation of the alternative pathway of complement by skin immune deposits.

J. Saurat, L. Didierjean, L. Polla, 1985, The Journal of investigative dermatology.

Milk, cream and evaporated milk.

G. Steiger, R. Martens, 1986 .

Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage

J. Schifferli, C. Danielsson, G. Steiger, 1994, European journal of immunology.

A calcium-dependent cryoglobulin IgM kappa/polyclonal IgG.

J. Schifferli, J. Schifferli, G. Steiger, 1992, Journal of immunology.

The monodeiodination of triiodothyronine and reverse triiodothyronine in man: a quantitative evaluation of the pathway by the use of turnover rate techniques.

A. Burger, D. Engler, G. Steiger, 1984, The Journal of clinical endocrinology and metabolism.

Metabolism of complement factor D in renal failure.

J. Volanakis, J. Schifferli, K. Macon, 1988, Kidney international.

Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.

J. Schifferli, J. Paccaud, N. Madi, 1989, Clinical and experimental immunology.

Human immunoglobulins for intravenous administration: preparation and properties.

P. Kistler, G. Steiger, 1970, Progress in immunobiological standardization.

A simple two-step procedure for the preparation of the first component of human complement (C1) in its native form.

J. Schifferli, G. Steiger, 1985, Journal of immunological methods.

Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).

J. Schifferli, J. Paccaud, G. Steiger, 1986, Clinical and experimental immunology.

Difference inthebiological properties ofthetwoformsof thefourth component ofhumancomplement (C4)

G. Steiger, 1986 .

Release of vesicles enriched in complement receptor 1 from human erythrocytes.

H. Lutz, P. Stammler, J. Schifferli, 1993, Journal of immunology.

Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1)

J. Paccaud, N. Madi, G. Steiger, 1991, Clinical and experimental immunology.

Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes

S. Sadallah, J. Carpentier, J. Paccaud, 1994, The Journal of experimental medicine.